This federal contract IDV award is for the delivery of pregabalin capsules to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award, indefinite delivery contract was issued by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida.
The contract has a ceiling value of $18,098,362.00 and a period of performance from March 2, 2021 to March 1, 2022, with four one-year option periods. Exelan Pharmaceuticals will deliver pregabalin capsules in various dosages to support the healthcare needs of veterans, military personnel, and other federal beneficiaries through the VA's and DoD's Pharmaceutical Prime Vendor Programs. This contract was awarded as an unrestricted procurement with no set-aside designation, allowing Exelan to compete based on its capabilities and pricing. Exelan Pharmaceuticals has a track record of delivering a diverse range of pharmaceutical products to federal agencies, particularly the VA, through its expertise in manufacturing, distributing, and repackaging medications.
Generated 1/29/25, 9:10 AM